Cogniciti Announces Collaboration with Johnson & Johnson Innovation to Evaluate Online Cognitive Screening to Identify Individuals at Risk for Dementia (Baycrest press release):
“Cogniciti Inc., the Toronto-based developer of a 20-minute online cognitive test for adults concerned about memory changes, today announced a collaboration agreement with Janssen Pharmaceuticals, Inc. to evaluate online screening strategies for early identification of dementia.
The collaboration, facilitated by Johnson & Johnson Innovation, will explore the potential for [Read more…] about Cogniciti and Johnson & Johnson Innovation partner to improve cognitive screenings for early identification of dementia